Back to Authors

Coté, Michele L.

0000-0003-0312-1601

Mayo Clinic

Wayne State University

Citations 21

ATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, Nicholas J. , Jiao, Yuchen , Kopelovich, Levy, Petersen, Gloria M. , Gallinger, Steven , Schwartz, Ann G. , Axilbund, Jennifer E., Schulick, Richard D. , Ali, Syed Z. , Eshleman, James R. , Velculescu, Victor E. , Vogelstein, Bert , Papadopoulos, Nickolas , Hruban, Ralph H. , Kinzler, Kenneth W. , Yu, Jun , Bondy, Melissa L. , Syngal, Sapna , Coté, Michele L. , Goggins, Michael , Klein, Alison P.

Cancer Discovery | December 29, 2011 | Volume: 2 | Issue: 1 | Pages: 41-46

10.1158/2159-8290.cd-11-0194 Get It

Abstract Pancreatic cancers are the fourth most-common cause of cancer-related deaths in the Western world, with >200,000 cases reported in 2010. Although up to 10% of these cases occur in familial patterns, the hereditary basis for predisposition in the vast majority of affected families is unknown. We used next-generation sequencing, including whole-genome and whole-exome analyses, and identified heterozygous, constitutional, ataxia telangiectasia mutated (ATM) gene mutations in 2 kindreds with familial pancreatic cancer. Mutations segregated with disease in both kindreds and tumor analysis demonstrated LOH of the wild-type allele. By using sequence analysis of an additional 166 familial pancreatic cancer probands, we identified 4 additional patients with deleterious mutations in the ATM gene, whereas we identified no deleterious mutations in 190 spouse controls (P = 0.046). When we considered only the mostly severely affected families with 3 or more pancreatic cancer cases, 4 deleterious mutations were found in 87 families (P = 0.009). Our results indicate that inherited ATM mutations play an important role in familial pancreatic cancer predisposition. Significance: The genes responsible for the majority of cases of familial pancreatic ductal adenocarcinoma are unknown. We here identify ATM as a predisposition gene for pancreatic ductal adenocarcinoma. Our results have important implications for the management of patients in affected families and illustrate the power of genome-wide sequencing to identify the basis of familial cancer syndromes. Cancer Discovery; 2(1): 41–6. ©2011 AACR. Read the Commentary on this article by Bakker and de Winter, p. 14 This article is highlighted in the In This Issue feature, p. 1